Melanoma inhibitory activity/cartilage-derived retinoic acid-sensitive protein (MIA/CD-RAP) is a small soluble protein secreted from chondrocytes. It was identified as the prototype of a family of extracellular proteins adopting an SH3 domain-like fold. In order to study the consequences of MIA/CD-RAP deficiency in detail we used mice with a targeted gene disruption of MIA/CD-RAP (MIAÀ/À) and analyzed cartilage organisation and differentiation in in vivo and in vitro models. Cartilage formation and regeneration was determined in models for osteoarthritis and fracture healing in vivo, in addition to in vitro studies using mesenchymal stem cells of MIAÀ/À mice. Interestingly, our data suggest enhanced chondrocytic regeneration in the MIAÀ/À mice, modulated by enhanced proliferation and delayed differentiation. Expression analysis of cartilage tissue derived from MIAÀ/À mice revealed strong downregulation of nuclear RNA-binding protein 54-kDa (p54 nrb ), a recently described modulator of Sox9 activity. In this study, we present p54 nrb as a mediator of MIA/CD-RAP to promote chondrogenesis. Taken together, our data indicate that MIA/CD-RAP is required for differentiation in cartilage potentially by regulating signaling processes during differentiation. Cell Death and Disease (2010) 1, e97; doi:10.1038/cddis.2010.78; pubished online 11 November 2010
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Melanoma inhibitory activity/cartilage-derived retinoic acid-sensitive protein (MIA/CD-RAP) was cloned as a secreted protein from human melanoma cell lines 1, 2 and independently identified by differential display comparing differentiated with dedifferentiated chondrocytes. 3 Several studies indicate an important role of MIA/CD-RAP in tumor progression and metastasis of malignant melanoma by mediating cell detachment from extracellular matrix molecules such as fibronectin. 4 In situ hybridization of mouse embryos revealed MIA/CD-RAP expression starting from the beginning of chondrogenesis and abundant throughout cartilage development. 3, 5 Moreover, MIA/CD-RAP was revealed to be a specific marker for chondrocytic differentiation. 6 Cartilage damage due to rheumatoid arthritis or mechanical overload, for instance during marathon running, releases MIA/ CD-RAP from the chondroid matrix and can be monitored clinically by enhanced MIA/CD-RAP serum levels. 7, 8 Based on its highly restricted activity, the MIA/CD-RAP promoter was used to study transcriptional mechanisms mediating chondrocyte differentiation. Expression of a LacZ-reporter gene under control of the 2251 bp MIA/CD-RAP promoter was exclusively observed in cartilage. 9 These data suggested that MIA/CD-RAP may be functionally important for cartilage differentiation and for specific morphogenetic events during embryogenesis.
To study the consequences of MIA/CD-RAP deficiency in vivo we generated MIA/CD-RAP-deficient (MIAÀ/À) mice. 10 First data gained from the analysis of the MIAÀ/À mice indicate that MIA/CD-RAP function is required for the highly ordered fibrillar ultra structure of cartilage. Electronmicroscopic analyses reveal defects in collagen fiber density, diameter and arrangement as well as changes in the number and morphology of chondrocytic microvilli. 10 In a recent study, we could show that MIA/CD-RAP can influence cartilage differentiation. 11 MIA/CD-RAP was not able to induce chondrocytic differentiation of human mesenchymal stem cells on its own but induced differentiation mediated by transforming growth factor (TGF)-b3 and reverted osteogenic differentiation by BMP2 into more chondrogenic differentiation. Therefore, we aimed to analyse the molecular function of MIA/CD-RAP in cartilage differentiation using in vivo models for cartilage destruction and regeneration and in vitro models using mesenchymal stem cells of MIAÀ/À mice.
Results
In an initial study, we analyzed spontaneous emerging osteoarthritis (OA) in 2-years old mice and surprisingly revealed reduced OA in MIAÀ/À mice compared with WT (data not shown). We, therefore, aimed to analyze this finding in mouse models for cartilage destruction, regeneration and differentiation to reveal whether MIA is important for cartilage repair or cartilage resistance.
Models for osteoarthritis and fracture healing revealed enhanced cartilage repair in MIAÀ/À mice. To determine the effects of MIA/CD-RAP on cartilage under pathological situations we used MIA/CD-RAP-deficient mice in in vivo models for osteoarthritis and fracture healing. In both models cartilage degradation, regeneration and differentiation can be evaluated.
OA was induced in 6-week old mice by detaching the medial meniscotibial ligament from the tibia plateau and progression of OA was analyzed in mice knee joints after 10, 21 and 42 days. Interestingly, OA development scored by grade and stage was markedly reduced in MIAÀ/À mice compared with wild-type (WT) mice after 21 and 42 days ( Figure 1a) . Nevertheless, MIAÀ/À mice developed OA at all, which rose at day 21, but was remarkably reduced till day 42 pointing towards cartilage regeneration. Careful analyses of the medial part of knee joints in 42-days OA mice by hematoxylin and eosin (HE) staining revealed strong cartilage damage in WT mice in contrast to MIAÀ/À mice (Figure 1b) . Surprisingly, proliferating chondrocytes, illustrated by PCNA staining in the knee joints of mice 10 days after OA was induced, were observed in MIAÀ/À mice but not in WT (Figure 1c ). To analyse cartilage formation in MIAÀ/À mice in detail, we used the fracture model to observe de novo cartilage and bone formation in the callus. Bone formation was normal or even slightly reduced (Figure 1d ). Interestingly, cartilage formation was significantly elevated in MIAÀ/À mice at day 7 after fracture. At day 9 and 11 the overall percentage of cartilage 50μm   50μm   50μm   100μm   100μm   100μm   50μm   50μm   50μm   100μm   100μm   100μm   50μm   50μm   50μm   100μm   100μm   100μm   50μm 100μm 50μm 100μm Figure 1 (a-c) Osteoarthritis (OA) was reduced in MIAÀ/À mice, mediated by enhanced proliferation. An experimental osteoarthritis model was used, in which instability to knee joints was created by detaching the medial meniscotibial ligament from the tibia plateau of 6-week old WT and MIAÀ/À mice. (a) After 10, 21 and 42 days OA development was scored by grade and stage. OA was markedly reduced in MIAÀ/À mice. We observed enhanced cartilage regeneration at day 42 in MIAÀ/À mice. (Figure 1e ). Hence, raised cartilage formation in MIAÀ/À was due to enhanced proliferation at early time points of fracture healing.
Accelerated proliferation and delayed differentiation in MIAÀ/À murine mesenchymal stem cells (mMSC). As these models suggest accelerated proliferation of early chondrocytes before differentiation, we examined the effect of loss of MIA/CD-RAP on proliferation of primary mMSC derived from WT and MIAÀ/À littermates. Dynamic cell-cycle kinetic was analyzed in vitro through continued 5-bromo-2-deoxyuridine (BrdU) incubation using the flow cytometric BrdU/Hoechst quenching method in which up to three consecutive cell cycles can be investigated. RNA-array analysis of murine chondrocytes derived from MIAÀ/À and WT littermates revealed upregulation of Cyclin D2 in MIAÀ/À chondrocytes (unpublished data). Cyclin D2 (CCND2) gene is a member of type-D cyclin family, which binds to and activates cyclin-dependent kinase (CDK) 4/6. 12 Activated CCND2-CDK4/6 complex phosphorylates downstream proteins, which are essential for cell-cycle progression from G1-to S-phase. Cyclin D2 is therefore an important initiator of proliferation. 13 We determined differential Cyclin D2 mRNA expression by quantitative real-time PCR (qRT-PCR) and protein levels per western blot in chondrocyte progenitor cells. Murine mesenchymal stem cells from MIAÀ/À littermates were compared with WT. In-line with the gene-array analysis, the relative CCND2 mRNA and protein expression was significantly higher in MIAÀ/À MSC (Figure 2c I ). Thus loss of MIA/ CD-RAP resulted in increased CCND2 expression, which promotes enhanced proliferation.
To confirm these results we used siRNA against MIA/CD-RAP in WT mMSC and re-expressed human MIA (hMIA) in MIAÀ/À mMSC, respectively. The efficiency of knocking down MIA/CD-RAP was shown by qRT-PCR ( Figure 2d In order to examine the effect of MIAÀ/À on proliferation under chondrogenic conditions, proliferation of mesenchymal stem cells derived from WT and MIAÀ/À mice was analyzed in monolayer cultures by XTT assay over 8 days. Chondrogenic differentiation was induced by TGF-b3. TGF-b3 is implicated in the process of endochondral ossification, which is initiated by the inhibition of proliferation of mesenchymal stem cells and differentiation into chondrocytes.
14 It, therefore, initiates a decline in proliferation of mesenchymal cells and promotes differentiation. In WT mMSC, relative proliferation was significantly reduced through treatment with TGF-b3 compared with MIAÀ/À mMSC where relative proliferation remained unchanged (Figure 2e To show the impact of MIA/CD-RAP on cartilage differentiation on transcriptional level, transcriptional activation of the Col2a1 promoter, an early marker for cartilage differentiation, 15 was analyzed in mMSC originated from WT and MIAÀ/À mice using a reporter gene assay. Differentiation was induced by TGF-b3. There was significant less activation of the Nuclear RNA-binding protein 54-kDa (p54 nrb ) is downregulated in cartilage of MIAÀ/À mice. In a study to identify MIA/CD-RAP regulated genes in malignant melanoma, a Powerblot analysis of MIAÀ/À cell clones of the melanoma cell line Hmb2 16 was performed. P54 nrb was found to be a MIA/CD-RAP-regulated gene (Figure 3a) . Alerted by a recent study presenting an important role of p54 nrb in enhancing Sox9-mediated transcription of Col2a1, 17 we concentrated on this MIA/CD-RAP target gene. Expression analysis of p54 nrb mRNA levels in cartilage of ear and sternum of adult mice (Figure 3b ), as well as on protein levels in rips of 15.5-days old mouse embryos, using p54 nrb -specific antibodies in immunohistochemistry (Figure 3c ), revealed strong downregulation of p54 nrb in MIAÀ/À mice. Next, we analyzed expression of p54 nrb during redifferentiation of dedifferentiated chondrocytes in threedimensional (3D) pellet cultures. We revealed strong induction of expression in WT chondrocytes, whereas p54 nrb expression in MIAÀ/À cells was markedly reduced (Figure 3d ).
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nrb is not regulated by ERK signalling. It is known that MIA/CD-RAP can inhibit ERK activity through negative regulation of integrin alpha 5 activity. 18 In a recent study, inhibition of ERK signaling by MIA/CD-RAP could be confirmed in chondrocytes through binding to integrin alpha 5. 11 Therefore, the role of ERK signaling on the regulation of p54 nrb expression was analyzed. The ERK signalling pathway was specifically inhibited using the MEK1/2 inhibitors PD98059 and UO126 in WT MSC. The results revealed no regulation of p54 nrb expression, neither on mRNA nor on protein level (Figure 5a ). 
Discussion
It is known that MIA/CD-RAP is strongly induced at the beginning of chondrogenesis during fetal development 3 and expressed throughout cartilage development. 5 As MIA/CD-RAP was revealed to be a specific marker for chondrocytic differentiation, 6 there is evidence for its role in cartilage development. Since the molecular function of MIA/CD-RAP in cartilage and bone formation was not analyzed in detail so far, we aimed to understand the role of MIA/CD-RAP nrb was overexpressed showed significant reduction in proliferation when treated with TGF-b3 (I). WT cells in which p54 nrb expression was knocked down by siRNA showed no alteration in relative proliferation (II). The data are represented as means ± S.D., after normalization to untreated cells. Simultaneous reexpression of MIA/CD-RAP and knockdown of p54 nrb in MIAÀ/À mMSC indicated no difference in relative proliferation, whereas reexpression of hMIA alone led to reduction of proliferation (III). Differentiation was induced by TGF-b3. The data are represented as means ± S.D., after normalization to untreated cells. (ns, not significant; *Po0.05; **Po0.01; ***Po0.001) in cartilage development. Previously, we could show that MIA/CD-RAP can modulate BMP2-induced osteogenic differentiation towards chondrogenic differentiation. 19 In more detail, we could demonstrate inhibition of ERK signalling by MIA/CD-RAP, mediated through binding of MIA/CD-RAP to integrin alpha 5 and inhibiting its activity. Active ERK signalling is known to block chondrogenic differentiation, so MIA/CD-RAP stabilizes cartilage differentiation and inhibits differentiation into bone. 11 Additionally, MIA/CD-RAP-deficient mice showed a disordered spatial arrangement of chondrocytes and an enlarged layer of calcified cartilage in articular cartilage indicating changes of cartilage maturation possibly involving an altered temporal pattern of proliferation. 11 These results further support the hypothesis of MIA/CD-RAP being an important element in cartilage development.
As MIAÀ/À mice are viable, develop normally and histological examination of cartilage by means of light microscopy revealed no major abnormalities, 10 we focused first on in vivo models, in which cartilage formation and regeneration could be studied. Here, we present in vivo models for fracture healing and osteoarthritis, which clearly showed enhanced chondrocytic regenerative capacity under MIA/CD-RAP deficiency. In a model for osteoarthritis, proliferating chondrocytes could be determined for the first time because of loss of MIA/CD-RAP clearly illustrating the highly regenerative potential in mature cartilage. Consequently, proliferating chondrocytes together with their increased matrix production not only counteract development of lesions in MIAÀ/À mice as seen at day 21 of OA compared with WT but also promotes enhanced regeneration at day 42, although OA proceeds in WT. The score of MIAÀ/À mice 42 days after OA induction decreased to the level of the control group, which leaves no doubt to the enhanced regenerative capacity by loss of MIA/CD-RAP. In fracture healing we revealed that cartilage formation proceeds faster in MIAÀ/À mice compared with WT through forced proliferation of collagen type II-positive undifferentiated chondrocytes under MIA/CD-RAP deficiency. However, as also seen in the adult MIA-deficient mice, the overall amount of cartilage did not differ hinting to secondary regulation counteracting lack of MIA/CD-RAP during development.
In cell-culture experiments we revealed that regeneration is enabled by the lack of MIA/CD-RAP through enhanced proliferation of mesenchymal stem cells and delayed differentiation during chondrogenesis. Enhanced proliferation is mediated by cell-cycle regulation through upregulation of Cyclin D2 expression promoting progression from G1 to S phase of cell cycle. Loss of MIA/CD-RAP decelerated differentiation exemplified by reduced Col2a1 promoter activity and by a delay in aggrecan mRNA expression (data not shown).
In this study, we could identify p54 nrb as a mediator of MIA/ CD-RAP in this regulation. Recent studies revealed that p54 nrb physically interacts with Sox9 and enhances Sox9-dependent transcriptional activation of the Col2a1 promoter, which leads to progression of chondrogenesis. 17 We were able to show that MIA/CD-RAP modulates chondrogenesis by initiating a stop of proliferation and inducing differentiation in both cases through p54 nrb . P54 nrb mediates differentiation through enhanced Sox9-dependent Col2a1 expression, whereas inhibition of proliferation is mediated by negative cell cycle regulation through Cyclin D2. The original findings that MIA/CD-RAP expression is regulated by the transcription factor Sox9 20 and AP-2 21 (Figure 5b ) has to be modified in a way that MIA/CD-RAP can also act upstream of Sox9 to promote differentiation (Figure 5c ). It is known that the MIA/ CD-RAP promoter contains a SOX consensus sequence to which the Sox9 protein is able to bind, leading to a dosedependent increased activity of the promoter. 20 MIA/CD-RAP is specifically expressed during chondrogenesis 5 and generally considered to be characteristic of cartilage.
3 Surprisingly, Sox9 is not able to induce endogenous CD-RAP expression in mesenchymal cells in contrast to chondrocytes, which implies that other factors are involved in chondrogenesis, 20 to induce the chondrocyte phenotype. This finding matches with our results, as we could show that in mesenchymal stem cells MIA/CD-RAP acts upstream from Sox9 and promotes chondrogenesis in early stages through p54 nrb . We could reveal no regulation of p54 nrb by MIA/CD-RAP through ERK-signalling and have to further analyse the regulation of p54 nrb through MIA/CD-RAP. In summary, our data indicate that MIA/CD-RAP is required for differentiation in cartilage upstream of the transcription . Most impressively, the lack of MIA/CD-RAP expression results in cartilage repair and enhanced proliferation of cartilage precursor cells. We feel that this investigation of MIA/CD-RAP in cartilage will help to understand its molecular impact and will give new insight in the approach of developing therapies for cartilage regeneration in arthritis.
Materials and Methods
Mice. Transgenic animals were generated as described previously.
10 C57Bl/6 control and MIA/CD-RAP-knockout mice were bred under specified pathogen-free conditions at 261C, 70% relative humidity, and a 12-h light/12-h dark cycle at the University of Regensburg. They were fed with a breeding/maintenance diet (Altromin GmbH, Lage, Germany) and water ad libitum. The mice were randomly housed in polypropylene cages with sawdust bedding. The cages were sanitised twice weekly. Embryos were harvested on day 15.5 days post-coitum (dpc), whereas day 0.5 was on the day of detection of the vaginal plug. Animal care and all experimental procedures were carried out in accordance with guidelines of the German law governing animal care. Experiments were approved by the Ethics Committee for Animal Research of the Bavarian government.
Animal studies. Cartilage formation and regeneration was determined in models for osteoarthritis and fracture healing in vivo. Osteoarthritis in 6-week old mice (MIAÀ/À and WT) was induced by detaching the medial meniscotibial ligament from the tibia plateau. Briefly, under general anesthesia using intraperitoneal injections of Ketamin (90 mg kg
À1
) and Xylazin (10 mg/kg), the bilateral hind limbs were prepared for aseptic surgery. The knee joint was exposed following a medial incision without transection of the patellar ligament. Then, the medial meniscus was removed using a surgical microscope. After replacement of the extensor muscle, the medial incision was sutured, and the skin was closed. During the procedure, close attention was paid not to injure the articular cartilage. The mice were killed at day 10, and 3 and 6 weeks after operation, and the knees were dissected, fixed in 4% paraformaldehyd in phosphate-buffered saline (PBS), decalcified in 20% ethylene diamine tetraacetic acid (EDTA, Sigma, Taufkirchen, Germany), and paraffin embedded. Sections (5 mm) were cut, stained with HE, and the progress of OA was scored by stage and grade using the scoring system proposed by Pritzker et al. 22 To analyse proliferating cells, PCNA staining was performed as described below.
For fracture healing, 6-8-weeks old mice (MIAÀ/À and WT) of both genders were used. After anesthesia with an intraperitoneal injection of Ketamin (90 mg kg
) and Xylazin (10 mg kg À1 ) standardized non-stable fractures were produced distal to the crest of the tibia in accordance with the German animal protective law (Grant no. 54-2531.1-12/05). The mice were killed by CO2-intoxication at days 5, 7, 9 and 11 after fracture. The fractured tibia and the collateral, unfractured control tibiae were dissected, fixed in 4% freshly prepared paraformaldehyde in PBS, and paraffin embedded for immunohistological analysis. Sections (4 mm) were cut through the long axis of each tibia in a sagittal plane and adjacent sections were stained with Weigert's hematoxylin/alcian blue/sirius red (Sigma) or processed for immunohistochemistry. To evaluate the expression and localization of collagen type II, collagen type X and PCNA in the callus tissue during fracture healing, the following antibodies were used: mouse anti collagen type II (Developmental studies hybridoma bank, Iowa, USA), mouse anti collagen type X (Quartett, Berlin, Germany), and mouse anti PCNA (Dako, Hamburg, Germany). The deparaffinized and rehydrated serial sections were heat treated with 0.1 M citrate buffer, pH 6.0 in case of PCNA and preincubated with protease XXIV (Sigma; 0.05% in PBS for 10 min at 371C) and testicular hyaluronidase (Sigma; 0.1% in acetate buffer, pH 6.0, for 90 min at 371C) in case of collagen type II and X. After the pre-treatment, the sections were washed several times in PBS and briefly incubated with 0.3% H 2 O 2 for 10 min at room temperature to block endogenous peroxidase activity. For the staining, a commercial biotinylation kit was used (ARK, Dako). The sections were counterstained in Weigert's hematoxylin, dehydrated and mounted. Sections incubated without the primary antibody served as a negative control. No sections showed any staining in such control experiments (data not shown). The evaluation of the staining was performed semiquantitatively by light microscopy. For histomorphometry, the callus proximally of the fracture line along the extensor side of the tibia was defined as the region of interest. To determine the cartilage and bone content in this region of interest, sagittal sections stained with Weiger's hematoxylin/alcian blue/sirius red from all time points and tibial growth plates from fractured and unfractured legs were photographed using a digital camera (DS-5M, Nikon, Düsseldorf, Germany). The images were imported into PhotoShop, and the software was used to select the areas of cartilage and bone in each callus. For the quantification of the selected pixels UTHSCSA ImageTool was used. The image software Eclipse-Net (Nikon) was used for the following histomorphometrical measurements: determination of the diameter of hypertrophic chondrocytes, and the quantification of hypertrophic chondrocytes per area.
Cell isolation and cell culture of primary murine MSCs and chondrocytes. MSCs were isolated from bone marrow of tibia and femur of 6-8-weeks old mice and grown in vitro in Dulbecco modified Eagle medium (DMEM) (PAA, Pasching, Austria), consisting of high glucose (Sigma), 20% fetal calf serum (FCS; PAN Biotech GmbH, Aidenbach, Germany), MEM vitamins (Invitrogen, Karlsruhe, Germany), penicillin (100 U per ml), streptomycin (10 mg ml À1 ) (both Sigma), and Amphotericin B (2.5 mg ml À1 ) (PAN Biotech GmbH) and were incubated in humidified atmosphere containing 5% CO 2 at 371C. Medium was replaced 24 h after isolation to select for plastic-adherent cells and every 3 days thereafter. Confluent cultures (B3 Â 10 4 cells per cm 2 ) were passaged at 1 : 2. Cells were washed with PBS (pH 7.4, PAA) and were detached from culture flasks by incubating for 3 min at 371C in a PBS solution supplemented with 0.05% trypsin and 0.02% ethylenediaminetetraacetic acid (Invitrogen). All experiments were performed at passage three to six.
MSC were treated with DMSO, UO126 and PD098059, respectively, (all CALBIOCHEM, Nottingham, UK) and incubated for 48 h followed by RNA and protein isolation.
BrdU/Hoe-quenching technique. For BrdU/Hoechst33258 (Hoe)-quenching measurements, 5 Â 10 5 cells were seeded on day 0 into T25 culture flasks (Corning Inc., Corning, NY, USA) and were incubated for 7 days. On day 3 and 5 after cell seeding, medium was changed and cells were treated with 120 mM BrdU (Sigma). To minimize potential disturbance in the nucleotide pathway due to BrdU treatment, medium was also supplemented with half-equimolar 2 0 -deoxycytidine (Sigma). 23 For BrdU/Hoe-quenching cell staining, cells were harvested on day 7 through trypsination and washed twice with ice cold DNAwashing buffer (100 mM Tris-HCl pH 7.4, 154 mM NaCl, 1 mM CaCl 2 , 0.5 mM MgCl 2 , 0.2% bovine serum albumin (BSA)) (all Merck, Darmstadt, Germany). A total of 5 Â 10 5 cells were resuspended in 0.5 ml DNA-staining buffer (100 mM Tris-HCl, pH 7.4, 154 mM NaCl, 1 mM CaCl 2 , 0.5 mM MgCl 2 , 0.2% BSA (all Merck), 0.1% IGEPAL CA-630 (Nonylphenyl-polyethylenglycol) (Sigma) supplemented with 40 mg ml À1 (2-4 U per ml) RNase (Roche Applied Science, Mannheim, Germany) and 1.2 mg ml À1 Hoechst 33258 (Sigma) and incubated for 15 min at 371C. 24, 25 Cellular DNA content was stained with PI (1.5 mg ml À1 ) (Sigma) for 15 min on ice.
Flow cytometry instrumentation and data analysis. An LSR-I three laser flow cytometer (Becton Dickinson Biosciences, San Jose, CA, USA) was used for BrdU/Hoe-quenching measurements. A 325 nm ultraviolet laser line was used for Hoe excitation. PI fluorescence was excited with an air-cooled 488 nm argon laser. Fluorescence emission was detected through 425/44 band-pass and 630/22 band-pass filter optic, respectively. Sample measurements and data analysis were performed with Diva software 6.1.1 (Becton Dickinson Biosciences). Cell debris and aggregates were excluded from analysis using pulse processing (DNA width signal against DNA area signal). By drawing regions around the initial G0 cell fraction (Figure 3a) , we identified cells that remained BrdU negative within a period of 96 h of BrdU incubation time, indicating quiescent cells. Quantification of cell cycle distribution was performed with FlowJo software (Tree Star Inc., Ashland, OR, USA).
siRNA knockdown. MSCs were transfected with gene-specific siRNA against p54 nrb purchased from Qiagen (Hilden, Germany) or MIA/CD-RAP purchased from Sigma. A negative scramble siRNA (Qiagen) was used as a control. Transfection was performed according to the manufacturer's specification using Lipofectamine 2000 reagent (Invitrogen). At 2 days after transfection, cells were harvested for RNA isolation and plated for proliferation assays as described elsewhere. For Luciferase assay cells were used after 1 day of transfection as described below.
Nucleofection with plasmid DNA. Nucleofection of mMSC was performed using the Human MSC Nucleofector Kit from Lonza (Basel, Switzerland).
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Manufacturer's instructions have been slightly modified. A total of 1 Â 10 6 cells were resuspended in 100 ml complete nucleofector solution. The pCMX-PL1-human MIA/CD-RAP plasmid or the pCMV-SPORT6-hp54 nrb plasmid (ImaGenes, Berlin, Germany, BC028299) both under the regulation of a cytomegalovirus (CMV) enhancer/promoter element, was then added (2 mg per transfection sample) to the cell suspension. As a control, cells received the empty expression construct pCMX-PL1. The cell/DNA mixtures were transferred into certified cuvettes (Lonza) and transfected by using program C-17. Following the electroporation, the cells were incubated in culture medium pre-heated to 371C for 2 days, and then seeded for proliferation assays, luciferase assay and RNA harvest as described elsewhere.
Differentiation. For analysis of chondrogenesis murine MSC differentiation and chondrocyte redifferentiation was performed as 3D pellets. The 3D pellet culture facilitates the in vitro differentiation of mesenchymal stem cells into chondrocytes. 26 For this, 2.5 Â 10 5 cells were seeded into 15 ml polypropylene tubes (Greiner Bio-One GmbH, Frickenhausen, Germany) and pelleted at 150 r.c.f. for 2 min. Cells were cultured for the indicated period as 3D pellets in induction medium including DMEM (PAA), high glucose (Sigma), 20% FCS (PAN Biotech GmbH), MEM Vitamins (Invitrogen), penicillin (100 U/ml), streptomycin (10 mg/ml) (both Sigma), Amphotericin B (2.5 mg/ml) (PAN Biotech GmbH), 0.1 mM dexamethasone, 1 mM sodium pyruvate, 0.17 mM ascorbic acid-2-phosphate, 0.35 mM proline (all Sigma), insulin (5 mg/ml), transferring (5 mg), selenious acid (5 ng) (ITS Premix, Becton Dickinson, Minneapolis, MN, USA) and 10 ng/ml human TGF-b3 (R&D Systems). The medium was changed every second day. All groups were done in triplicate. Each experiment was repeated three times. RNA was harvested at days 2, 4 and 6 in case of mMSC and every day between 1 and 6 days in case of chondrocytes.
RNA isolation and RT-PCR. Total RNA from cell culture, tissue (sternum and ear of 6-8-weeks old mice) or 3D pellets was isolated using e.Z.N.A. MicroElute Total RNA Kit (peqlab Biotechnologie GmbH, Erlangen, Germany) as described by the manufacturers. Each three mMSC pellets were pooled and total RNA was isolated after indicated days of culture. RNA concentration and purity was measured by NanoDrop (peqlab Biotechnologie GmbH). cDNA was generated by RT. The RT reaction was performed in 20 ml reaction volume containing 500 ng of total RNA, 4 ml of 5 Â first-strand buffer, 2 ml of 0.1 M DTT (both Invitrogen), 1 ml of dN 6 primer (10 mM) (Roche, Mannheim, Germany), 1 ml of dNTPs (10 mM) (Amersham pharmacia biotech, Pittsburgh, PA, USA) and DEPC water. The reaction mix was incubated for 10 min at 701C. Then 1 ml of Superscript II reverse transcriptase (Invitrogen) was added, and RNA was transcribed for 1 h at 371C. Subsequently, reverse transcriptase was inactivated at 701C for 10 min, and RNA was degraded by digestion with 1 ml RNase A (10 mg/ml) (Roche) at 371C for 30 min. The quality of cDNA was controlled and normalized by qRT-PCR amplification of the house keeping gene b-actin.
Quantitative real-time PCR. Quantitative RT-PCR was performed with a Lightcycler (Roche). A volume of 2 ml cDNA template, 0.5 ml of forward and reverse primer (20 mM) for each collagen type II, p54 nrb or Cyclin D2 and 10 ml of SYBR Premix Ex Taq (TaKaRa, Otsu, Japan) were combined to a total volume of 20 ml. PCR primers were obtained from Sigma.
The PCR program used was 30 s, 951C (initial denaturation); 201C s À1 temperature transition rate upto 951C for 3 s; 10 s 581C; 8 s 721C, 851C acquisition mode single, repeated for 40 times (amplification). Annealing and acquisition temperatures were optimized for each primer set. The PCR product was evaluated by melting-curve analysis according to the manufacturer's instructions and checking the PCR products on 1.8% agarose gels. Each analysis was performed at least in triplicate. The expression ratios of the analyzed genes were calculated using an internal control standard curve of b-actin levels. Primers used for PCR are shown in Table 1 .
Luciferase assay. For transient transfections, 2 Â 10 5 mMSC were seeded into each well of a six-well plate and transfected with 0.5 mg plasmid DNA using the Lipofectamine plus method (Gibco, Karlsruhe, Germany) according to the manufacturer's instruction. Cells were cultured in induction medium (see above) including 10 ng/ml human TGF-b3 (R&D Systems) to induce chondrogenic differentiation. The cells were lysed 24 h after transfection and the luciferase activity in the lysate was quantified by a luminometric assay (Promega Corp., Madison, WI, USA). Transfection efficiency was normalized according to renilla luciferase activity by cotransfecting 0.1 mg of the plasmid pRL-TK (Promega, Mannheim, Germany). All transfections were repeated at least three times. For transient transfection the COL2A1 LUC reporter construct 27 kindly provided by Linda J. Sandell was used.
Cell proliferation kit II (XTT). Cells were seeded as monolayer cultures in 100 ml cultivation medium (see above) without phenol red in a 96-well plate (Corning Inc.) at a density of 1 Â 10 4 and 2 Â 10 4 cells per well and incubated in humidified atmosphere containing 5% CO 2 at 371C for the indicated time periods. Experiments were performed in triplicates. Medium was changed after 4 days. Differentiation was induced by 10 ng/ml TGF-b3 (R&D Systems). After 2, 4, 6 and 8 days of incubation, 50 ml of XTT labeling and electron-coupling reagent (Roche) was added to the respective well, and plates were incubated at 371C. Absorbance was measured after 2 and 4 h of incubation at 450 nm against a reference wavelength at 650 nm using a microplate reader (Molecular Devices, Sunnyvale, CA, USA, Emax precision microplate reader).
Western blotting. Cells were lysed in 75 ml RIPA buffer (Roche) and incubated for 15 min at 41C. Insoluble fragments were removed by centrifugation at 16 100 r.c.f. for 10 min at 41C and the supernatant was stored at À201C. Protein concentrations were determined using the BCA protein assay reagent (Pierce, Rockford, IL, USA). In all, 75 mg (Cyclin D2) and 50 mg (p54 nrb ) protein per lane were denatured at 701C for 10 min after addition of Roti-load-buffer (Roth, Karlsruhe, Germany) and subsequently separated on 12-15% SDS-PAGE gels. After blotting onto PVDF-membranes (Bio-Rad, Richmond, CA, USA) and blocking for 1 h with 3% BSA/PBS (p54 nrb ) and 5% milk/TBST (0.1%) (Cyclin D2), respectively, membranes were incubated overnight at 41C with one of the following antibodies: anti-p54 nrb (BD Biosciences, Bedford, MA, USA), anti-CyclinD2 (Abcam, Cambridge, UK), and anti b-actin (Sigma, Deisenhofen, Germany). After three washing steps with PBS and TBST (0.1%), respectively, the membrane was incubated for 1 h with an alkaline phosphate-coupled secondary anti-mouse IgG antibody (Chemicon, Hofheim, Germany) and then washed again. Finally, immunoreactions were visualized by BCIP/NBT (Sigma) staining.
Immunohistochemistry. Paraffin-embedded preparations of 15.5-days old WT and MIAÀ/À embryos were screened for p54 nrb protein expression by immunohistochemistry. Samples were deparaffinised, rehydrated, heat treated with Tris-EDTA and subsequently incubated with primary monoclonal mouse anti p54 nrb antibody (1 : 10000; BD Biosciences) for 30 min at room temperature. The secondary antibody Envision (Dako) was incubated for 30 min at room temperature. Antibody binding was visualized using DAB-Chromogen (Dako). Finally, the tissues were counterstained by hematoxylin. The evaluation of the staining was performed semi quantitatively by light microscopy. Col2a1 rev  GGA CCA TCA TCT CCA GGT TCT CC  p54nrb for  GGC TTT GGC TTT ATT CGC TTG  356 bp  NM023144  p54nrb rev TCC ATA GGC TCC ACA GTC AC Ccnd2 for AAG GAG GTA AGG GAA GCA CTC 228 bp NM009829 Ccnd2 rev GAA ATA GGA ACA CTG CGG GAG
